3D Printed Drugs Market Size & Analysis by Application, Technology, Key Companies, Opportunities and Forecast 2022 To 2032


 The global 3D Printed Drugs Market is expected to reach a valuation of US$ 742.88 Mn in 2032, with the market expanding at a stellar CAGR of 9.2% from 2022 to 2032. The target market will likely generate an estimated US$ 307.54 Mn by the end of 2022. Large-scale applications in the healthcare sector along with the rise of chronic ailments fuel the growth of the 3D printed drugs market during the forecast period.

Quick solubility and customizable aspect of 3D printed drugs augments the demand for the same in the international market. These drugs are produced by the help of powder bed inkjet printing by adding the drug's components in a layer by layer format- similar to 3D printing for any other application. This process of production makes the medications easier to swallow and is advantageous for people suffering from dysphagia.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2336

Moreover, 3D printing has the potential to fasten up the arrival of customized pharmaceuticals or the development of therapeutic blends. With the help of 3D printing, medications could be personalized for each patient, which will likely be more effective than batch-produced medications as they would be produced individually with consideration for that patient's medical history. All of these considerations aid the growth of the 3D printed drugs market during the forecast period.

“A surge in the demand for customized medications will fuel the global growth of the 3D printed drugs market over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • The inkjet printer technology segment will hold 24% of the 3D printed drugs market share by the end of 2022.
  • The hospitals and clinics end-user segment will own about 45% of the overall market share.
  • In 2022, the 3D printed drugs market in North America will account for 31.1% of the total market share.
  • Europe’s 3D drug printing market will hold 29.9% of the market share in 2022.
  • Immense potential for 3D printed drugs research will drive the Asia Pacific market to hold 27% of the overall market share in 2022.

Competitive Landscape 

Hewlett Packard Caribe, Merck, Cycle Pharmaceuticals, AstraZeneca, Aprecia, Osmotica Pharmaceuticals, Aprecia Pharmaceuticals LLC Extend Biosciences, Bioduro, Affinity Therapeutics, GlaxoSmithKline Plc, and FabRx Ltd. among others are some of the major players in the 3D printed drugs market profiled in the full version of the report.

Key market players are focusing on product development and new product launches to meet the growing demand. These organizations also employ strategic partnership and collaboration tactics to gain a competitive advantage.

More Insights into 3D Printed Drugs Market Report

In its latest report, FMI offers an unbiased analysis of the global 3D printed drugs market, providing historical data from 2017 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of the dosage form (3D printed tablets, 3D printed capsules, 3D printed multi drug implants, 3D printed nanoparticles, 3D printed solutions, other 3D printed drug dosage forms), technology (inkjet 3D printed drugs, direct write 3D printed drugs, zip dose 3D printed drugs, thermal inkjet 3D printed drugs, 3D printed drugs based on fuel deposition modeling, powder bed 3D printed drugs, stereo lithography (SLA) 3D printed drugs, semi solid extrusion (SSE) 3D printed drugs), and region.

According to the latest FMI reports, based on segmentation, the inkjet printer technology will gain momentum over the forecast period. This segment will likely account for 24% of the 3D printed drugs market share in 2022. Owing to technological advancement the inkjet printers are easier and convenient to use. In terms of end use, hospitals and clinics are expected to be major contributors to the overall growth of the target market As easy installation and fewer waste fasten up the manufacture of 3D printed drugs in hospitals and clinics, these end users are predicted to hold 45% of the overall market share.

Based on region, the 3D printed drugs market in North America will exhibit impressive growth during 2022-2032. Increasing incidences of chronic diseases, an aging population, access to a well-established healthcare infrastructure are some of the factors that drive the target market in this region. Thus, the 3D printed drugs market in North America will account for 31.1% of the total market share in 2022. Besides North America, Europe and the Asia Pacific regions, too, will register considerable 3D printed drugs market growth during the forecast period. 

Key Companies Profiled

  • Hewlett Packard Caribe
  • Merck
  • Cycle Pharmaceuticals
  • AstraZeneca
  • Aprecia
  • Osmotica Pharmaceuticals
  • Aprecia Pharmaceuticals LLC
  • Extend Biosciences
  • Bioduro
  • Affinity Therapeutics
  • GlaxoSmithKline Plc
  • FabRx Ltd

Key Segments Covered in the 3D Printed Drugs Industry Analysis

3D Printed Drugs Market by Dosage Form:

  • 3D Printed Tablets
  • 3D Printed Capsules
  • 3D Printed Multi Drug Implants
  • 3D Printed Nanoparticles
  • 3D Printed Solutions
  • Other 3D Printed Drug Dosage Forms

3D Printed Drugs Market by Technology:

  • Inkjet 3D Printed Drugs
  • Direct Write 3D Printed Drugs
  • Zip Dose 3D Printed Drugs
  • Thermal Inkjet 3D Printed Drugs
  • 3D Printed Drugs based on Fused Deposition Modeling
  • Powder Bed 3D Printed Drugs
  • Stereo Lithography (SLA) 3D Printed Drugs
  • Semi Solid Extrusion (SSE) 3D Printed Drugs

 

 

 

Comments

Post a Comment

Popular posts from this blog

Beyond COVID-19: A Look at Vaccines Market Post-Pandemic From 2023 to 2033

Image
 In recent years, the Vaccines Market has undergone a dramatic transition brought on by ground-breaking scientific discoveries and the pressing need for universal immunisation. The COVID-19 pandemic acted as a stimulus for a surge in vaccine demand that has prompted academics and pharmaceutical corporations to develop at a previously unheard-of rate. This blog examines the changing market environment for vaccines, highlighting significant trends, difficulties, and opportunities. Technology advancements like mRNA and vector-based platforms have completely changed how vaccines are developed. These innovative techniques have proven to be remarkably effective against contagious illnesses like COVID-19, opening the door for the development of new vaccines. In response to the pandemic, mRNA vaccines were developed and distributed quickly, showcasing the promise of these ground-breaking technology. Supercharge Your Knowledge: Dive into the Booming Vaccines market with Our Sample Report @ ht
Read more

Key Players Shaping the 3D Cell Culture Market: By 2022 to 2031

Image
  The global 3D cell culture market is anticipated to account for a growth rate of around 9.8% over the forecast period from 2022 to 2031. The global market is expected to account for around US$ 1.15 Billion in 2022 and attain a valuation of US$ 2.67 Billion by 2031. According to the analysis done by Future Market Insights, the global 3D cell culture market accounted for a CAGR of 4.8% in 2021. During the historical period of 2016 to 2021, the 3D cell culture market expanded at a CAGR of 7.1%. According to the studies conducted by Future Market Insights, the comparative analysis along with the market growth rate of the global 3D cell culture market is expected to show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS, However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 02 Basis Point Share (BPS). The global 3D cell culture market observes a drop in the BPS values owned to its disadvantage as compared to surface
Read more

Technological Advancements Fueling the Physiotherapy Equipment Market By 2023 to 2033

 The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly. The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole. Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Physiotherapy E
Read more